Position in EXEL
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$26,777,010
+$6,051,319 QoQ
Shares Held
492,134
+1.8% QoQ
Ownership
0.199%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#71
of 756 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 94%
Shared 6%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MASSACHUSETTS FINANCIAL SERVICES CO /MA/ holds $2,249,676,327 across 65 Biotechnology names. EXEL ranks #18 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
1,875,301 | $500,180,281 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
2,012,317 | $376,866,725 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,049 | $210,141,127 | |
| 4 | TECH |
BIO-TECHNE Corp
|
2,746,462 | $194,037,538 | |
| 5 | SRRK |
Scholar Rock Holding Corp
|
2,607,348 | $143,404,140 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
375,762 | $118,774,610 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
350,560 | $105,529,075 | |
| 8 | BNTX |
BioNTech SE
|
677,708 | $63,060,728 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,777,010 | 492,134 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $20,725,691 | 483,229 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $20,038,506 | 457,187 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $22,686,585 | 549,312 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $18,701,248 | 424,257 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $12,512,520 | 338,909 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $8,765,126 | 263,217 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $8,466,291 | 326,254 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $10,449,627 | 465,048 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $10,692,854 | 450,605 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $6,529,262 | 272,166 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $6,077,839 | 278,162 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $5,385,752 | 281,829 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $5,442,913 | 280,418 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $5,739,047 | 357,796 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,875,138 | 247,139 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $4,810,022 | 231,029 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $1,652,824 | 72,908 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $2,146,309 | 117,413 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $395,402 | 18,704 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $42,460,050 | 2,330,409 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $62,591,262 | 2,770,751 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $71,474,005 | 3,561,236 | Shares | Sole | 2021-05-12 | |
| 2020-09-30 | $83,021,856 | 3,395,577 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $53,239,940 | 2,242,626 | Shares | Sole | 2020-11-20 | |
| 2020-03-31 | $175,678 | 10,202 | Shares | Sole | 2020-11-20 | |
| No filing history on record for this holder in this stock. | ||||||